Change of Broker

RNS Number : 5622G

OKYO Pharma Corporation

02 March 2018

 

For immediate release

 2 March 2018

Okyo Pharma Corporation
("Okyo" or the "Company")

Change of Broker

The Company notes the announcement today regarding Beaufort Securities Limited ("BSL") and Beaufort Asset Clearing Services Limited ("BACSL") being placed into insolvency and that the Financial Conduct Authority (the "FCA") has imposed requirements on BSL and BACSL to cease all regulatory activity.

BSL is the broker to the Company pursuant to the AIM Rules for Companies (the "AIM Rules").  As a result of the requirements imposed by the FCA, BSL will no longer be able to provide broking services to the Company in accordance with the AIM Rules.

The Company is seeking to appoint a new broker as soon as possible and a further announcement will be made when this appointment is made.

This announcement contains inside information for the purposes of Article 7 of EU Regulation No. 596/2014 on market abuse.

Enquiries:

Okyo Pharma Corporation	Willy Simon, Chariman	[e-mail]
Beaumont Cornish	Michael Cornish Roland Cornish	[phone]
	Email: [e-mail]

ENDS

 

END

 

 

APPFKBDQBBKDPNK